Stocks and Investing
Stocks and Investing
Tue, January 18, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, January 17, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, January 14, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michael King Initiated (VINC) at Strong Buy and Held Target at $25 on, Jan 14th, 2022
Michael King of HC Wainwright & Co., Initiated "Vincerx Pharma, Inc." (VINC) at Strong Buy and Held Target at $25 on, Jan 14th, 2022.
Michael has made no other calls on VINC in the last 4 months.
There are 2 other peers that have a rating on VINC. Out of the 2 peers that are also analyzing VINC, 0 agree with Michael's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Michael
- Li Watsek of "Cantor Fitzgerald" Initiated at Buy and Held Target at $25 on, Thursday, December 23rd, 2021
- Jonathan Chang of "SVB Leerink" Initiated at Buy and Held Target at $24 on, Monday, November 1st, 2021
Contributing Sources